ArticlePain and therapy2026

Efficacy and Safety of Oral Zavegepant in Migraine Prevention: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Migraine.

Robert J Fountaine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.